Cost-Benefit Analysis of Epilepsy Treatment by the Neurologist

John W. Hawks

Ira J. Goodman, MD

Luther T. Clark, MD; Ernest Afflu, MD

Donald O. Castell, MD

Bruce Kinosian, MD

Charles A. Carter, PharmD, MBA; James Selevan, MD; Rowe B. Brookfield, PharmD

An Interview with Clifton Gaus, ScD, AHCPR Administrator

David J. Bryg, PhD; Robert J. Bryg, MD

Martin Zagari, MD; Kathleen F. Villa, MS; James W. Freston, MD, PhD

Isaac W. Hammond, MD, PhD, MPH; David M. Grossman, MD; Julie P. Jones; Helen Hull-Sanders; Philip W. Lundy, DO; William C. Steinmann, MD, MSc